Anti-Human IL23A Recombinant Antibody(Tildrakizumab)

Name: Anti-Human IL23A Recombinant Antibody(Tildrakizumab)
Brand: KMD Bioscience
SKU: YR1295

YR1295

科研级 Tildrakizumab ( 替曲吉珠单抗 ), Anti-IL23A Recombinant Antibody, Research Grade Tildrakizumab

DATASHEET MSDS

Product Description

Alias	科研级 Tildrakizumab ( 替曲吉珠单抗 ), Anti-IL23A Recombinant Antibody, Research Grade Tildrakizumab
Catalog Number	YR1295
Molecular Name	Tildrakizumab
Host	Mouse
Size	1mg, 5mg
Clonity	Monoclonal
Purity	>95% as determined by SDS-PAGE
Concentration	1mg/ml
Antibody Isotype	IgG1 Kappa
Formulation	PBS, pH7.5
Background	Tildrakizumab (trade name Ilumya (US)/Ilumetri (European Union)) is a monoclonal antibody designed for the treatment of immunologically mediated inflammatory disorders. It is approved for the treatment of adult patients with moderate-to-severe plaque psoriasis in the United States and the European Union.
CAS Number	1326244-10-3
Application	Neut, ELISA, IF, IP, FuncS, FCM, ICC
Storage Condition	It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
Remarks	This product is for research use only.
Shipping Condition	Shipped on ice packs.
Molecular Weight	144.4 kDa
Target	IL23A[Homo sapiens]

Login